Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients

Mi Jiao, Wenbo Sun, Lina Li, Chunyan Li, Jing Zhou, Qian Li, Lian Duan

DOI: 10.3389/fgene.2022.878123
Published: 2022-09-28
Container: Frontiers in Genetics
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fgene.2022.878123,
  title = {Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients},
  author = {Mi Jiao and Wenbo Sun and Lina Li and Chunyan Li and Jing Zhou and Qian Li and Lian Duan},
  year = {2022},
  journal = {Frontiers in Genetics},
  doi = {10.3389/fgene.2022.878123},
  url = {https://doi.org/10.3389/fgene.2022.878123}
}

RIS

TY  - JOUR
TI  - Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients
AU  - Mi Jiao
AU  - Wenbo Sun
AU  - Lina Li
AU  - Chunyan Li
AU  - Jing Zhou
AU  - Qian Li
AU  - Lian Duan
PY  - 2022
JO  - Frontiers in Genetics
DO  - 10.3389/fgene.2022.878123
UR  - https://doi.org/10.3389/fgene.2022.878123
ER  -

APA

Jiao, M., Sun, W., Li, L., Li, C., Zhou, J., Li, Q., & Duan, L. (2022). Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients. Frontiers in Genetics. https://doi.org/10.3389/fgene.2022.878123

Source records

crossref · retrieved 2026-09-25T05:07:26.951Z